SERAFINI-LAMANNA TONY (Executive VP-Diagnostics) reported 1 transaction at MERIDIAN BIOSCIENCE INC
Review the transaction codes below to understand the nature of each event.
Filed: 11/17/2022ACC: 0001127602-22-025893
Officer· Executive VP-Diagnostics
Since May 2020
-3.67K
Net shares
Net seller
$116.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.67K
Price / share
$31.83
Trade value
$116.69K
% of position
9.4%
11/15/2022
39.06K→35.39K
Total
Net shares
−3.67K
Net value
-$116.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2022 | F · Tax Withholding | −3.67K | $31.83 | $116.69K | 9.4% | 39.06K | 35.39K |
| Total | −3.67K | -$116.69K | ||||||
Derivative Transactions0
No derivative transactions reported